Results 181 to 190 of about 165,540 (296)

Clinical Outcomes of Children With Autoimmune Hepatitis in Korea: A Nationwide Multicenter Study. [PDF]

open access: yesJ Korean Med Sci
Ahn JE   +16 more
europepmc   +1 more source

Checkpoint inhibitors, obinutuzumab plus PET‐adapted ultra‐low dose nodal radiotherapy yield high efficacy in treatment‐naïve follicular lymphoma: Results from the phase II ‘FLUORO’ study

open access: yesBritish Journal of Haematology, EarlyView.
Summary Follicular lymphoma (FL) first‐line chemoimmunotherapy yields high efficacy but serious toxicity in 65% of patients. In high tumour burden treatment‐naïve FL, we aimed to exploit known immunostimulatory and cytotoxic properties of combination checkpoint inhibition (atezolizumab) and obinutuzumab (6 cycles) with positron emission tomography (PET)
Arina Martynchyk   +15 more
wiley   +1 more source

Assessment of central blood volume in cirrhosis by radionuclide angiography [PDF]

open access: yes, 1994
Bendtsen, Flemming   +10 more
core  

Immunological features of acquired pure red cell aplasia: Specific human leucocyte antigen alleles, signal transducer and activator of transcription 3 mutations and a unique T‐cell receptor beta motif

open access: yesBritish Journal of Haematology, EarlyView.
Summary T‐cell abnormalities have been implicated in the pathogenesis of acquired pure red cell aplasia (PRCA), particularly in its major subtypes such as idiopathic PRCA, thymoma‐associated PRCA and large granular lymphocytic leukaemia (LGLL)–associated PRCA, and the precise details remain unclear.
Naruaki Yamashita   +11 more
wiley   +1 more source

Comparative evaluation of immunoserological detection of F-actin antibodies. [PDF]

open access: yesPLoS One
Dellbrügge F   +5 more
europepmc   +1 more source

Cholestatic Hepatitis in Young Migrants Exposed to Fuel Vapours: An Emerging Toxicity From the Mediterranean Sea

open access: yes
Acta Paediatrica, EarlyView.
Antonio Corsello   +4 more
wiley   +1 more source

Covalent drug discovery: Progress against key targets, emerging strategies and lessons learnt

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Covalent drug discovery is currently experiencing a boom in industrial and academic interest. To date, at least 75 covalent drugs have received regulatory approval, targeting both traditional target classes and more challenging proteins for which other approaches failed. In many cases, unique aspects of covalent targeting are essential for the
Charles P. Brown   +2 more
wiley   +1 more source

Drug-induced autoimmune hepatitis due to atorvastatin: a complex clinical case and literature review. [PDF]

open access: yesGastroenterol Rep (Oxf)
Serrano-Pérez NH   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy